SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-19-030591
Filing Date
2019-06-11
Accepted
2019-06-11 17:15:30
Documents
1
Period of Report
2019-06-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv523377_3.html 3  
1 OWNERSHIP DOCUMENT tv523377_3.xml 3 1546
  Complete submission text file 0001144204-19-030591.txt   3274
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Countouriotis Athena (Reporting) CIK: 0001571469 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36860 | Film No.: 19891737